Genmab Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2026 | 13.13 M | $360.77 M | 64.83% | 2.14% |
| ORBIS ALLAN GRAY LTD | 08/14/2026 | 11.37 M | $312.28 M | -12.05% | 1.85% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 8.64 M | $231.94 M | -9.55% | 1.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2026 | 6.87 M | $188.58 M | 178.84% | 1.12% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 5.65 M | $155.21 M | 54.23% | 0.92% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 4.98 M | $136.67 M | 0.00% | 0.81% |
| BLACKROCK, INC. | 08/07/2026 | 4.67 M | $128.32 M | 2.97% | 0.76% |
| SOFINNOVA INVESTMENTS, INC. | 08/14/2026 | 4.05 M | $111.12 M | 437.74% | 0.66% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 3.52 M | $96.64 M | -20.31% | 0.57% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 3.51 M | $96.33 M | 49.90% | 0.57% |
| HARDING LOEVNER LP | 08/14/2026 | 3.09 M | $86.90 M | -4.50% | 0.50% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 3.00 M | $82.41 M | 100.00% | 0.49% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 2.76 M | $75.72 M | 11.99% | 0.45% |
| CITADEL ADVISORS LLC | 08/14/2026 | 2.48 M | $68.02 M | 100.00% | 0.40% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 1.69 M | $46.40 M | 149.40% | 0.28% |
| MORGAN STANLEY | 08/13/2026 | 1.63 M | $44.78 M | -25.38% | 0.27% |
| FEDERATED HERMES, INC. | 08/12/2026 | 1.45 M | $39.81 M | 15.80% | 0.24% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.28 M | $35.14 M | 37.37% | 0.21% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 1.20 M | $33.04 M | 0.82% | 0.20% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 1.07 M | $29.28 M | -1.07% | 0.17% |
| UBS GROUP AG | 08/13/2026 | 961.05 K | $26.40 M | 222.36% | 0.16% |
| PERPETUAL LTD | 07/15/2026 | 919.05 K | $25.25 M | 21.17% | 0.15% |
| NORTHERN TRUST CORP | 08/13/2026 | 916.60 K | $25.18 M | -3.57% | 0.15% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 910.60 K | $25.01 M | 14.93% | 0.15% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/06/2026 | 883.43 K | $24.27 M | 10.84% | 0.14% |
| ENVESTNET ASSET MANAGEMENT INC | 08/03/2026 | 829.69 K | $22.79 M | -3.78% | 0.14% |
| MARSHALL WACE, LLP | 08/13/2026 | 829.66 K | $22.79 M | 5,431.06% | 0.14% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2026 | 804.37 K | $22.10 M | 24.62% | 0.13% |
| FMR LLC | 08/13/2026 | 764.69 K | $21.01 M | -24.42% | 0.12% |
| JPMORGAN CHASE & CO | 08/12/2026 | 744.82 K | $19.38 M | 234.59% | 0.12% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 698.00 K | $19.17 M | 100.00% | 0.11% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 599.95 K | $16.48 M | 11.32% | 0.10% |
| CIBC WORLD MARKET INC. | 08/13/2026 | 514.76 K | $14.14 M | 5.43% | 0.08% |
| OPPENHEIMER ASSET MANAGEMENT INC. | 08/03/2026 | 447.43 K | $12.29 M | -2.20% | 0.07% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 08/14/2026 | 430.60 K | $11.83 M | 118.90% | 0.07% |
| MOORE CAPITAL MANAGEMENT, LP | 08/14/2026 | 420.49 K | $11.55 M | 98.62% | 0.07% |
| DIXON MITCHELL INVESTMENT COUNSEL INC. | 08/13/2026 | 416.00 K | $11.43 M | 100.00% | 0.07% |
| QUANTINNO CAPITAL MANAGEMENT LP | 08/13/2026 | 333.39 K | $9.16 M | 18.01% | 0.05% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 08/14/2026 | 330.00 K | $9.07 M | 6.45% | 0.05% |
| SUMMITTX CAPITAL, L.P. | 08/14/2026 | 318.41 K | $8.75 M | 277.47% | 0.05% |
| CITADEL ADVISORS LLC | 08/14/2026 | 312.30 K | $8.58 M | 81.04% | 0.05% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 303.64 K | $8.34 M | -4.99% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 259.25 K | $7.12 M | 7.34% | 0.04% |
| EAGLE GLOBAL ADVISORS LLC | 07/30/2026 | 244.73 K | $6.72 M | 0.07% | 0.04% |
| ASSETMARK, INC | 07/30/2026 | 238.80 K | $6.56 M | 6.54% | 0.04% |
| JANE STREET GROUP, LLC | 08/14/2026 | 237.30 K | $6.52 M | 125.79% | 0.04% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 227.99 K | $6.26 M | 0.18% | 0.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 221.40 K | $6.08 M | 107.30% | 0.04% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 199.77 K | $5.49 M | 100.00% | 0.03% |
| FOLKETRYGDFONDET | 08/13/2026 | 165.08 K | $4.53 M | 2.68% | 0.03% |
Genmab institutional Ownership - FAQ's
During the previous two years, 391 institutional investors and hedge funds held shares of Genmab. The most heavily invested institutionals were:
Paradigm Biocapital Advisors LP: 13.13 M
Orbis Allan Gray Ltd: 11.37 M
ALLIANCEBERNSTEIN L.P.: 8.64 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 6.87 M
Deep Track Capital, LP: 5.65 M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP: 4.98 M
16.69% of Genmab stock is owned by institutional investors.
Institutional investors have bought a total of 115.19 M shares in the last 24 months. This purchase volume represents approximately $3.14 B in transactions.